Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.2.0.727
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Statements of Operations [Abstract]        
Revenue        
Operating expenses:        
Research and development, net of reimbursements $ 3,837,959 $ 2,130,625 $ 7,886,673 $ 3,720,401
General and administrative 3,550,361 2,285,939 7,356,766 4,833,184
Depreciation expense 16,194 8,052 26,589 9,457
Total operating expenses 7,404,514 4,424,616 15,270,028 8,563,042
Loss from operations (7,404,514) $ (4,424,616) (15,270,028) $ (8,563,042)
Other income (expense):        
Interest expense (1,553)   (7,280)  
Gain (loss) on change in fair value of derivative liabilities (57,668) $ 7,939,711 4,738,710 $ (4,621,360)
Total other income (expense) (59,221) 7,939,711 4,731,430 (4,621,360)
Net (loss) income $ (7,463,735) $ 3,515,095 $ (10,538,598) $ (13,184,402)
Net (loss) income per common share - basic $ (0.20) $ 0.14 $ (0.30) $ (0.52)
Net (loss) income per common share - diluted $ (0.20) $ 0.10 $ (0.30) $ (0.52)
Weighted average common shares outstanding - basic 36,650,803 25,795,573 34,959,125 25,513,505
Weighted average common shares outstanding - diluted 36,650,803 35,862,173 34,959,125 25,513,505